NC
MDT icon

Nekton Capital’s Medtronic MDT Stock Holding History

Nekton Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.14M Buy
+54,000
New +$4.96M 10.42% 2
2022
Q4 		– Sell
-163,275
Closed -$13.2M – 22
2022
Q3 		$13.2M Buy
+163,275
New +$14.7M 3.59% 10

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nekton Capital's MDT Position: Q3 2025 in Review

Nekton Capital opened a new position in Medtronic (MDT) in Q3 2025: 54,000 shares worth $5.14M. The stake represents 10.42% of the portfolio and ranks #2 among its holdings. This is a return to the name: Nekton Capital previously reported a position in MDT as recently as Q3 2022.

Nekton Capital first reported a position in MDT in Q3 2022 and has held it in 2 quarters since. The position peaked at $13.2M in Q3 2022. 2,170 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Nekton Capital held 54,000 shares of Medtronic worth $5.14M as of Q3 2025.
  • Medtronic was a new Nekton Capital position in Q3 2025.
  • Medtronic made up 10.42% of Nekton Capital's portfolio in Q3 2025, its #2 holding.
  • Nekton Capital first reported a position in Medtronic in Q3 2022 and has held it in 2 quarters since.
  • Nekton Capital's Medtronic position peaked at $13.2M in Q3 2022.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Nekton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.